| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | positive regulation of Arp2/3 complex-mediated actin nucleation | 3.21e-07 | 8 | 38 | 3 | GO:2000601 | |
| GeneOntologyBiologicalProcess | positive regulation of actin nucleation | 2.07e-06 | 14 | 38 | 3 | GO:0051127 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to growth factor stimulus | 8.91e-06 | 412 | 38 | 7 | GO:0090287 | |
| GeneOntologyBiologicalProcess | regulation of Arp2/3 complex-mediated actin nucleation | 2.50e-05 | 31 | 38 | 3 | GO:0034315 | |
| GeneOntologyBiologicalProcess | regulation of alkaline phosphatase activity | 4.93e-05 | 6 | 38 | 2 | GO:0010692 | |
| GeneOntologyBiologicalProcess | regulation of actin nucleation | 5.86e-05 | 41 | 38 | 3 | GO:0051125 | |
| GeneOntologyBiologicalProcess | Arp2/3 complex-mediated actin nucleation | 8.85e-05 | 47 | 38 | 3 | GO:0034314 | |
| GeneOntologyBiologicalProcess | positive regulation of neurotrophin TRK receptor signaling pathway | 9.19e-05 | 8 | 38 | 2 | GO:0051388 | |
| GeneOntologyBiologicalProcess | negative regulation of epithelial to mesenchymal transition | 1.49e-04 | 56 | 38 | 3 | GO:0010719 | |
| GeneOntologyBiologicalProcess | negative regulation of cellular response to growth factor stimulus | 1.64e-04 | 150 | 38 | 4 | GO:0090288 | |
| GeneOntologyBiologicalProcess | Rac protein signal transduction | 1.84e-04 | 60 | 38 | 3 | GO:0016601 | |
| GeneOntologyBiologicalProcess | actin nucleation | 2.33e-04 | 65 | 38 | 3 | GO:0045010 | |
| GeneOntologyBiologicalProcess | establishment of T cell polarity | 3.42e-04 | 15 | 38 | 2 | GO:0001768 | |
| GeneOntologyBiologicalProcess | establishment of lymphocyte polarity | 3.90e-04 | 16 | 38 | 2 | GO:0001767 | |
| GeneOntologyBiologicalProcess | regulation of neurotrophin TRK receptor signaling pathway | 4.42e-04 | 17 | 38 | 2 | GO:0051386 | |
| GeneOntologyBiologicalProcess | lamellipodium morphogenesis | 4.96e-04 | 18 | 38 | 2 | GO:0072673 | |
| GeneOntologyBiologicalProcess | positive regulation of cytoskeleton organization | 5.37e-04 | 205 | 38 | 4 | GO:0051495 | |
| GeneOntologyCellularComponent | SCAR complex | 1.21e-06 | 12 | 38 | 3 | GO:0031209 | |
| Domain | SCAR/WAVE_fam | 1.14e-05 | 3 | 37 | 2 | IPR028288 | |
| Domain | WH2 | 3.42e-04 | 14 | 37 | 2 | SM00246 | |
| Domain | WH2 | 4.50e-04 | 16 | 37 | 2 | PF02205 | |
| Domain | LRR | 6.51e-04 | 201 | 37 | 4 | PS51450 | |
| Domain | WH2_dom | 7.83e-04 | 21 | 37 | 2 | IPR003124 | |
| Domain | LRR_1 | 8.97e-04 | 219 | 37 | 4 | PF00560 | |
| Domain | WH2 | 1.03e-03 | 24 | 37 | 2 | PS51082 | |
| Domain | FYVE | 1.50e-03 | 29 | 37 | 2 | PF01363 | |
| Domain | FYVE | 1.50e-03 | 29 | 37 | 2 | SM00064 | |
| Domain | Leu-rich_rpt | 1.96e-03 | 271 | 37 | 4 | IPR001611 | |
| Domain | Znf_FYVE-rel | 2.06e-03 | 34 | 37 | 2 | IPR017455 | |
| Domain | Znf_FYVE | 2.57e-03 | 38 | 37 | 2 | IPR000306 | |
| Domain | ZF_FYVE | 2.84e-03 | 40 | 37 | 2 | PS50178 | |
| Domain | - | 3.62e-03 | 321 | 37 | 4 | 3.80.10.10 | |
| Domain | L_dom-like | 3.91e-03 | 328 | 37 | 4 | IPR032675 | |
| Domain | LRR_8 | 4.66e-03 | 171 | 37 | 3 | PF13855 | |
| Domain | Leu-rich_rpt_typical-subtyp | 5.13e-03 | 177 | 37 | 3 | IPR003591 | |
| Domain | LRR_TYP | 5.13e-03 | 177 | 37 | 3 | SM00369 | |
| Domain | HEAT_REPEAT | 8.47e-03 | 70 | 37 | 2 | PS50077 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SALMONELLA_SOPE_TO_RAC_SIGNALING_PATHWAY | 8.72e-06 | 20 | 29 | 3 | M47737 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ARNO_ARF_ACTB_G_SIGNALING_PATHWAY | 1.75e-05 | 25 | 29 | 3 | M47716 | |
| Pathway | REACTOME_DOWNREGULATION_OF_TGF_BETA_RECEPTOR_SIGNALING | 1.97e-05 | 26 | 29 | 3 | M628 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SHIGELLA_IPGD_TO_ARNO_ARF_ACTB_G_SIGNALING_PATHWAY | 2.76e-05 | 29 | 29 | 3 | M47717 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SALMONELLA_SOPB_TO_ARNO_ARF_ACTB_G_SIGNALING_PATHWAY | 3.06e-05 | 30 | 29 | 3 | M47738 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_WASPS_AND_WAVES | 4.49e-05 | 34 | 29 | 3 | MM15265 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_WASPS_AND_WAVES | 5.34e-05 | 36 | 29 | 3 | M27549 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 6.29e-05 | 38 | 29 | 3 | MM14874 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 1.19e-04 | 47 | 29 | 3 | M646 | |
| Pathway | BIOCARTA_ACTINY_PATHWAY | 1.82e-04 | 10 | 29 | 2 | MM1528 | |
| Pathway | BIOCARTA_ACTINY_PATHWAY | 2.66e-04 | 12 | 29 | 2 | M7825 | |
| Pathway | REACTOME_DOWNREGULATION_OF_TGF_BETA_RECEPTOR_SIGNALING | 4.82e-04 | 16 | 29 | 2 | MM14873 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 5.17e-04 | 77 | 29 | 3 | MM14670 | |
| Pathway | BIOCARTA_TGFB_PATHWAY | 6.84e-04 | 19 | 29 | 2 | M18933 | |
| Pathway | REACTOME_RAC3_GTPASE_CYCLE | 8.97e-04 | 93 | 29 | 3 | MM15609 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 9.25e-04 | 94 | 29 | 3 | M1041 | |
| Pathway | REACTOME_RAC3_GTPASE_CYCLE | 9.25e-04 | 94 | 29 | 3 | M41818 | |
| Pathway | REACTOME_SIGNALING_BY_VEGF | 1.21e-03 | 103 | 29 | 3 | MM14752 | |
| Pathway | REACTOME_SIGNALING_BY_VEGF | 1.31e-03 | 106 | 29 | 3 | M27077 | |
| Pathway | REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS | 1.61e-03 | 114 | 29 | 3 | MM14814 | |
| Pathway | REACTOME_PARASITE_INFECTION | 1.70e-03 | 116 | 29 | 3 | M29843 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 1.78e-03 | 118 | 29 | 3 | MM15588 | |
| Pathway | REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS | 3.08e-03 | 143 | 29 | 3 | M27107 | |
| Pubmed | 6.71e-08 | 8 | 38 | 3 | 21107423 | ||
| Pubmed | 1.01e-07 | 9 | 38 | 3 | 38981622 | ||
| Pubmed | Abi1 is essential for the formation and activation of a WAVE2 signalling complex. | 1.44e-07 | 10 | 38 | 3 | 15048123 | |
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 32697617 | ||
| Pubmed | Phosphorylation of WAVE2 by MAP kinases regulates persistent cell migration and polarity. | 1.16e-06 | 2 | 38 | 2 | 18032787 | |
| Pubmed | Regulation of WAVE1 expression in macrophages at multiple levels. | 1.16e-06 | 2 | 38 | 2 | 18765479 | |
| Pubmed | Smad7 Knockdown Restores Aryl Hydrocarbon Receptor-mediated Protective Signals in the Gut. | 1.16e-06 | 2 | 38 | 2 | 26818761 | |
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 34755534 | ||
| Pubmed | Genomic organization and expression profile of the human and mouse WAVE gene family. | 3.48e-06 | 3 | 38 | 2 | 12856283 | |
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 30119997 | ||
| Pubmed | SMURF2 and SMAD7 induce SARA degradation via the proteasome. | 3.48e-06 | 3 | 38 | 2 | 32283253 | |
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 9732292 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 15280206 | ||
| Pubmed | Characterization of the WAVE1 knock-out mouse: implications for CNS development. | 3.48e-06 | 3 | 38 | 2 | 12716942 | |
| Pubmed | Expression and subcellular localization of WAVE isoforms in the megakaryocyte/platelet lineage. | 3.48e-06 | 3 | 38 | 2 | 15670045 | |
| Pubmed | Neutrophils establish rapid and robust WAVE complex polarity in an actin-dependent fashion. | 6.96e-06 | 4 | 38 | 2 | 19200726 | |
| Pubmed | 6.96e-06 | 4 | 38 | 2 | 22179776 | ||
| Pubmed | 6.96e-06 | 4 | 38 | 2 | 17664349 | ||
| Pubmed | Sra-1 and Nap1 link Rac to actin assembly driving lamellipodia formation. | 6.96e-06 | 4 | 38 | 2 | 14765121 | |
| Pubmed | 6.96e-06 | 4 | 38 | 2 | 32915464 | ||
| Pubmed | 6.96e-06 | 4 | 38 | 2 | 27605705 | ||
| Pubmed | Interaction between Wiskott-Aldrich Syndrome protein (WASP) and the Fyn protein-tyrosine kinase. | 6.96e-06 | 4 | 38 | 2 | 10532312 | |
| Pubmed | WAVE2 is required for directed cell migration and cardiovascular development. | 1.16e-05 | 5 | 38 | 2 | 12879075 | |
| Pubmed | IL-17A-Induced PLET1 Expression Contributes to Tissue Repair and Colon Tumorigenesis. | 1.16e-05 | 5 | 38 | 2 | 29070673 | |
| Pubmed | 1.16e-05 | 5 | 38 | 2 | 9307968 | ||
| Pubmed | Local F-actin network links synapse formation and axon branching. | 1.16e-05 | 5 | 38 | 2 | 24439377 | |
| Pubmed | FBP11 regulates nuclear localization of N-WASP and inhibits N-WASP-dependent microspike formation. | 1.16e-05 | 5 | 38 | 2 | 14697212 | |
| Pubmed | 1.74e-05 | 6 | 38 | 2 | 25745180 | ||
| Pubmed | 1.74e-05 | 6 | 38 | 2 | 25527710 | ||
| Pubmed | 1.74e-05 | 6 | 38 | 2 | 10970852 | ||
| Pubmed | 1.74e-05 | 6 | 38 | 2 | 9804817 | ||
| Pubmed | Interleukin-22 protects intestinal stem cells against genotoxic stress. | 1.74e-05 | 6 | 38 | 2 | 30700914 | |
| Pubmed | Free Brick1 is a trimeric precursor in the assembly of a functional wave complex. | 2.43e-05 | 7 | 38 | 2 | 18560548 | |
| Pubmed | 2.43e-05 | 7 | 38 | 2 | 30687000 | ||
| Pubmed | Quick validation of genetic quality for conditional alleles in mice. | 2.43e-05 | 7 | 38 | 2 | 33540482 | |
| Pubmed | 2.43e-05 | 7 | 38 | 2 | 9889097 | ||
| Pubmed | 2.43e-05 | 7 | 38 | 2 | 22890011 | ||
| Pubmed | 3.24e-05 | 8 | 38 | 2 | 10381382 | ||
| Pubmed | IRSp53 is an essential intermediate between Rac and WAVE in the regulation of membrane ruffling. | 3.24e-05 | 8 | 38 | 2 | 11130076 | |
| Pubmed | A systematic evaluation of protein kinase A-A-kinase anchoring protein interaction motifs. | 3.24e-05 | 8 | 38 | 2 | 25097019 | |
| Pubmed | 3.24e-05 | 8 | 38 | 2 | 24519940 | ||
| Pubmed | Interaction of WASP/Scar proteins with actin and vertebrate Arp2/3 complex. | 3.24e-05 | 8 | 38 | 2 | 11146629 | |
| Pubmed | Mechanism of regulation of WAVE1-induced actin nucleation by Rac1 and Nck. | 3.24e-05 | 8 | 38 | 2 | 12181570 | |
| Pubmed | Confirmed rare copy number variants implicate novel genes in schizophrenia. | 4.16e-05 | 9 | 38 | 2 | 20298200 | |
| Pubmed | IL-17R-EGFR axis links wound healing to tumorigenesis in Lrig1+ stem cells. | 4.16e-05 | 9 | 38 | 2 | 30578323 | |
| Pubmed | 5.20e-05 | 10 | 38 | 2 | 26376988 | ||
| Pubmed | NESH (Abi-3) is present in the Abi/WAVE complex but does not promote c-Abl-mediated phosphorylation. | 5.20e-05 | 10 | 38 | 2 | 17101133 | |
| Pubmed | Mindbomb 1, an E3 ubiquitin ligase, forms a complex with RYK to activate Wnt/β-catenin signaling. | 5.49e-05 | 67 | 38 | 3 | 21875946 | |
| Pubmed | 6.81e-05 | 72 | 38 | 3 | 33726789 | ||
| Pubmed | 7.28e-05 | 963 | 38 | 7 | 28671696 | ||
| Pubmed | Topologically associating domain boundaries are required for normal genome function. | 7.62e-05 | 12 | 38 | 2 | 37081156 | |
| Pubmed | WAVE1 is required for oligodendrocyte morphogenesis and normal CNS myelination. | 9.00e-05 | 13 | 38 | 2 | 16723544 | |
| Pubmed | Stability of the cancer target DDIAS is regulated by the CHIP/HSP70 pathway in lung cancer cells. | 9.00e-05 | 13 | 38 | 2 | 28079882 | |
| Pubmed | 9.00e-05 | 13 | 38 | 2 | 25908663 | ||
| Pubmed | Rac1 signaling is critical to cardiomyocyte polarity and embryonic heart development. | 1.05e-04 | 14 | 38 | 2 | 25315346 | |
| Pubmed | 1.56e-04 | 17 | 38 | 2 | 16831833 | ||
| Pubmed | 1.76e-04 | 18 | 38 | 2 | 9463375 | ||
| Pubmed | NYAP: a phosphoprotein family that links PI3K to WAVE1 signalling in neurons. | 2.65e-04 | 22 | 38 | 2 | 21946561 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | 3.58e-04 | 565 | 38 | 5 | 25468996 | |
| Pubmed | Mutations in LZTR1 drive human disease by dysregulating RAS ubiquitination. | 4.01e-04 | 27 | 38 | 2 | 30442762 | |
| Pubmed | 4.40e-04 | 591 | 38 | 5 | 15231748 | ||
| Pubmed | 4.96e-04 | 30 | 38 | 2 | 38218976 | ||
| Pubmed | 5.17e-04 | 143 | 38 | 3 | 32560809 | ||
| Pubmed | 6.01e-04 | 33 | 38 | 2 | 34841685 | ||
| Pubmed | 6.01e-04 | 33 | 38 | 2 | 26296893 | ||
| Pubmed | 6.22e-04 | 638 | 38 | 5 | 33239621 | ||
| Pubmed | α-catenin interaction with YAP/FoxM1/TEAD-induced CEP55 supports liver cancer cell migration. | 6.76e-04 | 35 | 38 | 2 | 37381005 | |
| Pubmed | 8.39e-04 | 169 | 38 | 3 | 31462741 | ||
| Pubmed | 8.97e-04 | 1049 | 38 | 6 | 27880917 | ||
| Pubmed | 9.28e-04 | 41 | 38 | 2 | 8590280 | ||
| Pubmed | 9.92e-04 | 708 | 38 | 5 | 39231216 | ||
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | 9.94e-04 | 1070 | 38 | 6 | 23533145 | |
| Interaction | ZFPL1 interactions | 1.22e-05 | 448 | 36 | 7 | int:ZFPL1 | |
| Cytoband | 3q23 | 6.17e-04 | 44 | 38 | 2 | 3q23 | |
| Cytoband | 5q32 | 9.29e-04 | 54 | 38 | 2 | 5q32 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q32 | 2.02e-03 | 80 | 38 | 2 | chr5q32 | |
| Cytoband | 6q21 | 2.90e-03 | 96 | 38 | 2 | 6q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6q21 | 4.55e-03 | 121 | 38 | 2 | chr6q21 | |
| GeneFamily | Wiskott-Aldrich Syndrome protein family | 2.36e-04 | 16 | 26 | 2 | 14 | |
| GeneFamily | Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors | 9.01e-04 | 31 | 26 | 2 | 81 | |
| Coexpression | GOLDRATH_NAIVE_VS_MEMORY_CD8_TCELL_DN | 1.01e-05 | 200 | 38 | 5 | M3039 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_DN | 7.32e-05 | 9 | 38 | 2 | MM482 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_DN | 9.14e-05 | 10 | 38 | 2 | M527 | |
| Coexpression | GSE9988_LPS_VS_LOW_LPS_MONOCYTE_DN | 1.50e-04 | 186 | 38 | 4 | M5855 | |
| Coexpression | GSE29618_PRE_VS_DAY7_FLU_VACCINE_BCELL_UP | 1.83e-04 | 196 | 38 | 4 | M4972 | |
| Coexpression | GSE14000_4H_VS_16H_LPS_DC_TRANSLATED_RNA_DN | 1.91e-04 | 198 | 38 | 4 | M3352 | |
| Coexpression | GSE43863_LY6C_INT_CXCR5POS_VS_LY6C_LOW_CXCR5NEG_EFFECTOR_CD4_TCELL_UP | 1.94e-04 | 199 | 38 | 4 | M9754 | |
| Coexpression | GSE25123_WT_VS_PPARG_KO_MACROPHAGE_IL4_STIM_DN | 1.98e-04 | 200 | 38 | 4 | M7958 | |
| Coexpression | GSE33162_UNTREATED_VS_4H_LPS_STIM_HDAC3_KO_MACROPHAGE_UP | 1.98e-04 | 200 | 38 | 4 | M9033 | |
| Coexpression | GSE19772_CTRL_VS_HCMV_INF_MONOCYTES_UP | 1.98e-04 | 200 | 38 | 4 | M7282 | |
| Coexpression | GSE23568_CTRL_TRANSDUCED_VS_WT_CD8_TCELL_UP | 1.98e-04 | 200 | 38 | 4 | M8522 | |
| Coexpression | GSE40068_CXCR5NEG_BCL6NEG_CD4_TCELL_VS_CXCR5POS_BCL6NEG_TFH_DN | 1.98e-04 | 200 | 38 | 4 | M9263 | |
| Coexpression | GSE17721_POLYIC_VS_PAM3CSK4_2H_BMDC_UP | 1.98e-04 | 200 | 38 | 4 | M3830 | |
| Coexpression | GSE9878_CTRL_VS_EBF_TRANSDUCED_PAX5_KO_PRO_BCELL_UP | 1.98e-04 | 200 | 38 | 4 | M6988 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | 2.01e-04 | 856 | 38 | 7 | M4500 | |
| ToppCell | MS-CD4-CD8_2|MS / Condition, Cell_class and T cell subcluster | 7.81e-06 | 149 | 38 | 4 | 08fb6be5599c5988890c851ce5ac6781c319948e | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.85e-06 | 158 | 38 | 4 | 216b3f482daa2d0d7fcaf5a8559e3ccbdb8e110d | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.85e-06 | 158 | 38 | 4 | 9712bb8b1bacb8a38c99a22bc2babec5d5160e2a | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Lymphocytic-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-05 | 170 | 38 | 4 | 3ad9f950b87ee98f025ab9b4a8ed551e6a9b4764 | |
| ToppCell | 11.5-Airway-Epithelial-Basal_cell|Airway / Age, Tissue, Lineage and Cell class | 1.38e-05 | 172 | 38 | 4 | 9d4d92e2d16dfc8a394f2641653bb97de20a2530 | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Dendritic-DC2|bone_marrow / Manually curated celltypes from each tissue | 1.38e-05 | 172 | 38 | 4 | 64928cea7e5b60e4bc4af016454b0173ebcc07c7 | |
| ToppCell | 3'_v3-bone_marrow-Myeloid_Dendritic-DC2|bone_marrow / Manually curated celltypes from each tissue | 1.75e-05 | 183 | 38 | 4 | f482e4fe011fa450a475034b1e25587233855bdb | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.79e-05 | 184 | 38 | 4 | a45980306c4e697a2703bed72a7b48fb23d942f4 | |
| ToppCell | mild-Myeloid-mDC|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.79e-05 | 184 | 38 | 4 | 8b37c00d59d9992d3b43268991da7bb94646c70e | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.79e-05 | 184 | 38 | 4 | 1c56378b3888c46258d446b47de4d6282fe74b0d | |
| ToppCell | COVID_non-vent-Myeloid-Dendritic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.91e-05 | 187 | 38 | 4 | 936aaca144b79a809617cbe3058bf434a4b3d46a | |
| ToppCell | COVID_non-vent-Myeloid-Dendritic-cDC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.91e-05 | 187 | 38 | 4 | 55fe4e8b4f301876716c1af15c34d42164f2358e | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-epithelial_progenitor_cell-Stem_cells|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.08e-05 | 191 | 38 | 4 | a8d77095ba20b47fc70ba04f80759fbce873253d | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-05 | 193 | 38 | 4 | 06b65110db974f4ef90d3511ff34428976a52c9c | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-05 | 193 | 38 | 4 | d8ccfb780a75bdf9141f41fb29a076958601ebb4 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-05 | 193 | 38 | 4 | 9c16032bc03df8760ae199e8f19fdafa4c3f1827 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-05 | 193 | 38 | 4 | a4f91bca5eaa985982d33a528f7566ffde154d47 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-05 | 193 | 38 | 4 | b39d7feaac4ff8f7409cd3d15e8f3c6391367275 | |
| ToppCell | 356C-Myeloid-Dendritic-cDC2|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.25e-05 | 195 | 38 | 4 | 4c9a2167d8cfe40dfd609c303ada5b5ef800bd8f | |
| ToppCell | healthy_donor-Myeloid-Dendritic-cDC|healthy_donor / Disease condition, Lineage, Cell class and subclass | 2.30e-05 | 196 | 38 | 4 | aac79fc45cab4a16e2fa02652ece0999591261a5 | |
| ToppCell | 356C-Myeloid-Dendritic|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.30e-05 | 196 | 38 | 4 | 1425eb35bd170d434c47390773e5c74c30c2f592 | |
| ToppCell | healthy_donor-Myeloid-Dendritic|healthy_donor / Disease condition, Lineage, Cell class and subclass | 2.30e-05 | 196 | 38 | 4 | ea590b8ea3d13ff93cb5863a44936b0cfdf3b868 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-cDC2-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.34e-05 | 197 | 38 | 4 | 4f7c10a636646dfc82a84026c1b5a36603367abe | |
| ToppCell | COVID-19_Moderate-cDC|COVID-19_Moderate / disease group, cell group and cell class | 2.34e-05 | 197 | 38 | 4 | ff45a212434a1b128e1a217c6abdec6380938da9 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-cDC2|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.39e-05 | 198 | 38 | 4 | da36c1bb62fdd1da7aca9c5115432a87fb48adb0 | |
| ToppCell | Healthy-cDC|Healthy / disease group, cell group and cell class | 2.39e-05 | 198 | 38 | 4 | 4cf874333b9fd6cd22ee647cd12c032fc6d05740 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_0|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.39e-05 | 198 | 38 | 4 | c1fe38594bd6292fcc60bdbb563376b454731d00 | |
| ToppCell | COVID-19_Severe-cDC|World / disease group, cell group and cell class | 2.39e-05 | 198 | 38 | 4 | c452334249f047265ae89dcabe7de446d968cae6 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_0|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.39e-05 | 198 | 38 | 4 | bfc15de70a7577a2860b53e1e6826a7b5ad23040 | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Dendritic_cell-DC_2|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.44e-05 | 199 | 38 | 4 | fdd8c4c04837341e17a4772a2adcdf2f187c56b1 | |
| ToppCell | control-HLA-DR+_CD83+_Monocyte|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.44e-05 | 199 | 38 | 4 | f1b370d2869ad29c9d8ff41fdcc486fffa781ee2 | |
| ToppCell | control-cDC|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.48e-05 | 200 | 38 | 4 | 4a6d17a4225be38537d3dd8a39512051f597f4e0 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Adora2a|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.10e-04 | 109 | 38 | 3 | e8e0f2c5f8c9e45f2b4d173569c94275eedfe432 | |
| ToppCell | PBMC-Control-Myeloid-Classical_Monocyte-Classical_Monocyte-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.44e-04 | 143 | 38 | 3 | 4c5a5db46beb8f2f3c40e8ed95911fbfea61bae0 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum_-18m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.87e-04 | 151 | 38 | 3 | 3105b8c0c401faa92e1ab8223d435b21ed45c5b7 | |
| ToppCell | Hippocampus-Macroglia-CSF_related|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.92e-04 | 152 | 38 | 3 | c2b6cc41546cbd46b9ea5d28a7c66f6330a27df2 | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_2|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.98e-04 | 153 | 38 | 3 | 151c469b26f9adf04dd6f117f03bef760cc3d45d | |
| ToppCell | facs-Brain_Myeloid-Cortex-3m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.98e-04 | 153 | 38 | 3 | 0ef7c45cdd854c79e527006034029767f8e108b2 | |
| ToppCell | normal_Lung-Myeloid_cells-Pleural_Mac|Myeloid_cells / Location, Cell class and cell subclass | 3.04e-04 | 154 | 38 | 3 | 835ef49d314ecbcbfd8d1041ba202a5eedcda0bd | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_dendritic-liver_dendritic_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.16e-04 | 156 | 38 | 3 | 411c170a7dd65269ae442b8069caf5231bddb116 | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 3.40e-04 | 160 | 38 | 3 | f843287ed57d2d5a3b3f6dfb03b6934e330e6645 | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 3.46e-04 | 161 | 38 | 3 | ebcd5066e82b7760b9da6adc02d11258d1309dab | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mast-Mast|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.52e-04 | 162 | 38 | 3 | 30508c4007faa38b76246e3c6d7b3fde4492cc85 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mast|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.52e-04 | 162 | 38 | 3 | 33b73c6727b5c5ada2dddf304f56d84397725ca8 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mast-Mast-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.52e-04 | 162 | 38 | 3 | 44ef0932ee38964ff11edc2aa14698d9db3b2b6b | |
| ToppCell | 343B-Fibroblasts-Fibroblast-D-|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.59e-04 | 163 | 38 | 3 | 8d2b2119c6b3d5b677da6f377fd85146590e1246 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-D|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.59e-04 | 163 | 38 | 3 | acfb2ece6202479e615d54fd3ecb8b4a571b5a18 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Classical_Dendritic_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.65e-04 | 164 | 38 | 3 | 43045879505774ac0d9b7f760557955564f06d00 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-CD141+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 3.78e-04 | 166 | 38 | 3 | 6210a136efb99d70c2026b6454363f1bd2723558 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-medium_spiny_neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.92e-04 | 168 | 38 | 3 | b96a48552f4236a95bbcdce2f1b05041086d7101 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.92e-04 | 168 | 38 | 3 | d60f7cd8269f373827f49c7785002cb38e4570a9 | |
| ToppCell | frontal_cortex-Non-neuronal-leptomeningeal_cell-VLMC-VLMC_Osr1_Mc5r|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.92e-04 | 168 | 38 | 3 | 9930bd63b60c03f0152838a79eef77da1c2dd8e5 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-SPN_Neuron_STR|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.92e-04 | 168 | 38 | 3 | b87fc63f9e35dfcfc46cb129ea569e73c5e018bb | |
| ToppCell | P28-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.92e-04 | 168 | 38 | 3 | 8c8dbdbc7053f34e4ca0c5067af502fbea109fc1 | |
| ToppCell | AT1-AT2_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 3.99e-04 | 169 | 38 | 3 | 815474855a70498a74e52f6583113c63b7267a0c | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_DC-DC-DC1|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.99e-04 | 169 | 38 | 3 | 488ba50631a64cb9e0d69219491c66ac824c9e7d | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.99e-04 | 169 | 38 | 3 | ccd98f9005aa0a88bd49f153be4e7200cc3dd0ac | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.13e-04 | 171 | 38 | 3 | 913bae728b5e653771a27c79a309eb023699f1d0 | |
| ToppCell | COVID-19_Convalescent-cDC-|COVID-19_Convalescent / Disease condition and Cell class | 4.13e-04 | 171 | 38 | 3 | fb5fae8b3adafcbb7c5618d887966b418355ed4d | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.13e-04 | 171 | 38 | 3 | f28b2336057e353b96a6ff4581ec9fd0ca0789d9 | |
| ToppCell | COVID-19_Convalescent-cDC|COVID-19_Convalescent / Disease condition and Cell class | 4.13e-04 | 171 | 38 | 3 | 9ccaa9f1629818b0f63a5d930ee78c01e04cd98d | |
| ToppCell | AT1-AT2_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 4.20e-04 | 172 | 38 | 3 | 0be41df5d35d818deb7316ac21c9366eb4b7bfd1 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.20e-04 | 172 | 38 | 3 | 73e9b29b1c6b8b016b495a0d20336d0c0761e5e2 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.27e-04 | 173 | 38 | 3 | 20889aa85e36ad3bafdb91b91e43964493c949f9 | |
| ToppCell | 10x5'-Lung-Myeloid_Dendritic-Cycling_Dendritic|Lung / Manually curated celltypes from each tissue | 4.27e-04 | 173 | 38 | 3 | 62e0c18cfed9645e34a9d7029c94a8554f773714 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.27e-04 | 173 | 38 | 3 | 46e601b7938b1dd0aa3df7aa056c4bd07b1620c1 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-mature_enterocytic-Paneth|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.34e-04 | 174 | 38 | 3 | b4483d7d9f22f09ed7fa0b72305434a47ccaade0 | |
| ToppCell | primary_visual_cortex-Non-neuronal-leptomeningeal_cell|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.34e-04 | 174 | 38 | 3 | 2891ab2fd05eb4bbd239d1a2865f21ef7f2df39e | |
| ToppCell | primary_visual_cortex-Non-neuronal-leptomeningeal_cell-VLMC|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.34e-04 | 174 | 38 | 3 | eade55f86ef1f7a5355ad65cec3aa6bfc5d3c62d | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Epithelial-epithelial_progenitor_cell-Proximal_progenitor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.41e-04 | 175 | 38 | 3 | 6759d200a133034756de9cdf2d5daceca927aac9 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-cDC2-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.49e-04 | 176 | 38 | 3 | a31d7532f8c055d4e62bbaa78d819f2495bfee00 | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Dendritic-DC2|lymph-node_spleen / Manually curated celltypes from each tissue | 4.49e-04 | 176 | 38 | 3 | 72a3bbab0540ae3e3c94b9573cdb9298a024dbc4 | |
| ToppCell | BAL-Severe-cDC_3|Severe / Compartment, Disease Groups and Clusters | 4.56e-04 | 177 | 38 | 3 | 939487a05311b66edfc3f44a7955fbf25266d6bf | |
| ToppCell | Endothelial-Endothelial-C|Endothelial / shred on cell class and cell subclass (v4) | 4.56e-04 | 177 | 38 | 3 | b5b9278dfd76b1aacd88e5fe86e91a2c9b565f87 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-mature_enterocytic-Paneth|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.72e-04 | 179 | 38 | 3 | 6405010e8136a4d9bab356f628e36e3194911112 | |
| ToppCell | mild_COVID-19_(asymptomatic)-cDC|World / disease group, cell group and cell class (v2) | 4.79e-04 | 180 | 38 | 3 | 68d1c867734fb2977b01ac686b20bf602f9a6b72 | |
| ToppCell | FLU-Healthy-0|FLU / Virus stimulation, Condition and Cluster | 5.03e-04 | 183 | 38 | 3 | 058604ddb06b3bef131183d86b83b422dae8f6cb | |
| ToppCell | IPF-Epithelial-ATI|World / Disease state, Lineage and Cell class | 5.03e-04 | 183 | 38 | 3 | 31fef35ecf30162662f24d335d8f0cceacc07039 | |
| ToppCell | COVID-19-APC-like-Dendritic_cells|COVID-19 / group, cell type (main and fine annotations) | 5.03e-04 | 183 | 38 | 3 | 703364836b42aa6ac6c68b42b700ac23c4a1afc7 | |
| ToppCell | Dendritic_Cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 5.03e-04 | 183 | 38 | 3 | dd09e39e8ca282ff0f470e0652d519e190badd0b | |
| ToppCell | IPF-Lymphoid-ILC_B|Lymphoid / Disease state, Lineage and Cell class | 5.03e-04 | 183 | 38 | 3 | 9b507547e6adf78e46e7f542cd9958224ec5826a | |
| ToppCell | COVID-19-APC-like|COVID-19 / group, cell type (main and fine annotations) | 5.03e-04 | 183 | 38 | 3 | b8f5afaf9ff1b2b1bc60be58654d1b23859dafa9 | |
| ToppCell | FLU-Healthy-0|Healthy / Virus stimulation, Condition and Cluster | 5.03e-04 | 183 | 38 | 3 | 7a6f18246c39864479e114f698581f667fa9c600 | |
| ToppCell | IPF-Epithelial-ATI|IPF / Disease state, Lineage and Cell class | 5.03e-04 | 183 | 38 | 3 | c0a3541c45bd0c587603521f392f42dd86c3c35b | |
| ToppCell | PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_dendritic-im_conventional_dendritic_(19)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.11e-04 | 184 | 38 | 3 | 315bb14e848d8e8e4533122047df6f9b89b89d99 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-3|TCGA-Lung / Sample_Type by Project: Shred V9 | 5.11e-04 | 184 | 38 | 3 | ea4ccebe2d54279fcc517e4f0bfa652b91a808bb | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 5.11e-04 | 184 | 38 | 3 | 6e17c8151d6dc543de16d804db956c63c3fda414 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-AT1-AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.19e-04 | 185 | 38 | 3 | 3bef59cc0aa939d2a7e52f0f6c61bc00528fe50b | |
| ToppCell | Control-Epithelial-ATI|World / Disease state, Lineage and Cell class | 5.19e-04 | 185 | 38 | 3 | 0563d5042bb96ecce8446fbf26d05ef7a45e23c5 | |
| ToppCell | droplet-Fat-Scat-21m-Mesenchymal-Cd34+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.19e-04 | 185 | 38 | 3 | 01bbe1e09f9ccae837a03ea2cdd168fa10800942 | |
| ToppCell | pdx-Tumor_cells-T0|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 5.19e-04 | 185 | 38 | 3 | 1d874608aa2062024323512f68889219471b2f00 | |
| ToppCell | droplet-Marrow-nan-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.19e-04 | 185 | 38 | 3 | 3dcafbd02b65a2befbb6e6288cb2591e721cddb6 | |
| ToppCell | droplet-Marrow-BM-30m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.19e-04 | 185 | 38 | 3 | 4157cc14b06bb99ee67ac1526622cf546e727efc | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-C|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.27e-04 | 186 | 38 | 3 | c30fd15f6b4b6edfbdf18a019aaad7fed3cf91fe | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 5.27e-04 | 186 | 38 | 3 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 5.27e-04 | 186 | 38 | 3 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | droplet-Marrow-nan-24m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.27e-04 | 186 | 38 | 3 | 332931f92352b464c7f23aeebf313cf7db6d499c | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_adipo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.36e-04 | 187 | 38 | 3 | f1d0fc625e0e7881b3f290742fd7148d995eb71e | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_adipo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.36e-04 | 187 | 38 | 3 | 02e7246ef5ad41773d14426254e139b156d45c1d | |
| ToppCell | droplet-Marrow-BM-1m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.36e-04 | 187 | 38 | 3 | 6be99f71532b7d679d1287ea1bb08245d9538db7 | |
| Disease | Congenital nystagmus | 1.53e-06 | 2 | 37 | 2 | C0700501 | |
| Disease | NEURAL TUBE DEFECTS, SUSCEPTIBILITY TO | 4.26e-05 | 8 | 37 | 2 | C3891448 | |
| Disease | bitter non-alcoholic beverage consumption measurement | 7.41e-04 | 32 | 37 | 2 | EFO_0010093 | |
| Disease | bitter beverage consumption measurement | 1.28e-03 | 42 | 37 | 2 | EFO_0010089 | |
| Disease | response to fenofibrate | 1.80e-03 | 50 | 37 | 2 | GO_1901557 | |
| Disease | squamous cell carcinoma | 3.21e-03 | 67 | 37 | 2 | EFO_0000707 | |
| Disease | Colorectal Neoplasms | 5.02e-03 | 277 | 37 | 3 | C0009404 | |
| Disease | monocyte count | 5.60e-03 | 1320 | 37 | 6 | EFO_0005091 | |
| Disease | nevus count, cutaneous melanoma | 5.84e-03 | 91 | 37 | 2 | EFO_0000389, EFO_0004632 | |
| Disease | hippocampal volume | 6.09e-03 | 297 | 37 | 3 | EFO_0005035 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LPQTVVCYNPDQIPP | 196 | P35869 | |
| VCYNPDQIPPENSPL | 201 | P35869 | |
| TLPCLPLPALFNQEP | 181 | P33076 | |
| APLCLDTDQPPYPRQ | 116 | Q86SQ6 | |
| YIPPPPCQPLINTTE | 461 | P18850 | |
| GQPLQYNLSICPPLL | 811 | Q9Y2K5 | |
| TELILLPPPCPASFN | 266 | Q9Y257 | |
| LPEPNSVPQQYQPCL | 1786 | Q8N7Z5 | |
| QPCIEPPPSSLLYQP | 26 | Q7L576 | |
| AASCPQPPTFLLPLL | 531 | P35052 | |
| PLPCSAPSVQLSYQP | 226 | O14498 | |
| PPLNCPPGLEYLSQI | 91 | O15162 | |
| PCYTTLTQILPPTEP | 726 | Q9Y233 | |
| PSQCLYEPQLSPPDV | 271 | Q05215 | |
| LFCLLPPVPPTQNAL | 556 | Q9H0A0 | |
| PLPLTEYIQPVCLPA | 266 | P05981 | |
| VPLNCPSPVPPLYLD | 996 | Q9NYA4 | |
| QNYTLPCLSPDAQPP | 66 | Q6EBC2 | |
| VLSCIPAPSLPYNQP | 686 | Q9UBF2 | |
| QLSEPCLYPEPLPAL | 426 | Q5T749 | |
| PLQCCLPAPPLEPYL | 256 | Q8N4L8 | |
| LCLLCGPSPPLSQLY | 246 | Q9BT04 | |
| GPSPPLSQLYPQLLE | 251 | Q9BT04 | |
| LPACLNPLLYILFNP | 811 | O75473 | |
| PRNPCQDPYILTPEN | 361 | Q12805 | |
| TYCLPQRKLPPQTPE | 296 | Q86YN6 | |
| NLPSLCLPNPEYLAP | 221 | Q6P3W7 | |
| SPLNSLPLYPNHPLC | 146 | Q8TE99 | |
| LTCYLLPQQPPPSLE | 411 | Q14160 | |
| PLTSVCYPQDLPRPL | 226 | O43734 | |
| ELQIPTPPLPSYCST | 586 | Q15468 | |
| PAQPPSSYSLPLLLC | 146 | O15105 | |
| LPPPALCYILTAHPN | 596 | Q14159 | |
| TCDTPPPLNNLTPYR | 126 | Q9Y6W5 | |
| LQPRPASPCPQVYLE | 71 | P0C7W0 | |
| PQPPPLCRALYNFDL | 186 | Q8TEC5 | |
| DVCEQPPPLNILTPY | 126 | Q92558 | |
| SQCRPQELDQPPPYS | 101 | Q8IV31 | |
| PNNPAEYCSTIPPLQ | 776 | O95405 | |
| VSYCPVLAPLPLLLP | 341 | Q86UW6 |